Recombinant Mouse Gzmc Protein，His

Gzmc, also known as Granzyme C, is a serine protease predominantly expressed in cytotoxic T lymphocytes and natural killer (NK) cells, and plays a pivotal role in the immune response by facilitating the apoptosis of target cells, particularly virally infected and tumor cells. Research on Gzmc recombinant proteins has gained momentum due to their potential applications in cancer immunotherapy and viral infections. The mechanism by which Gzmc induces apoptosis involves the cleavage of specific substrates within the target cell, leading to programmed cell death. Understanding the structural and functional properties of Gzmc through recombinant protein studies can enhance our comprehension of its enzymatic activity, substrate specificity, and the overall role in the immune system. Furthermore, the ability to produce Gzmc in a recombinant form allows for detailed biochemical analyses and the development of novel therapeutic strategies aimed at augmenting immune responses in various disease contexts. The exploration of Gzmc’s role in the immune landscape is crucial, as it provides insight into potential biomarkers for disease progression and therapeutic targets, particularly in the field of oncology. Consequently, the study of Gzmc recombinant proteins holds significant promise for advancing our understanding of immune mechanisms and developing innovative treatments that harness the body’s natural defense systems.